Authors:
Nutting, CM
Convery, DJ
Cosgrove, VP
Rowbottom, C
Vini, L
Harmer, C
Dearnaley, DP
Webb, S
Citation: Cm. Nutting et al., Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland, RADIOTH ONC, 60(2), 2001, pp. 173-180
Authors:
Szlosarek, PW
Lofts, FJ
Pettengell, R
Carter, P
Young, M
Harmer, C
Citation: Pw. Szlosarek et al., Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel, ANTI-CANC D, 11(4), 2000, pp. 275-278
Citation: Sl. Hyer et al., Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival, EUR J SUR O, 26(7), 2000, pp. 686-690
Citation: C. Harmer et al., Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?, CANC CAUSE, 10(5), 1999, pp. 333-337
Citation: C. Nutting et al., Failure of TSH rise prior to radio-iodine therapy for thyroid cancer: Implications for treatment, CL ONCOL-UK, 11(4), 1999, pp. 269-271
Authors:
Ashton, A
Balyckyi, J
Barton, R
Bolger, J
Cruickshank, C
Davidson, J
Dearnaley, D
Elyan, S
Harmer, C
Hoskin, P
Jose, C
Maitland, L
Melville, P
Meyer, L
Neal, A
Regan, J
Skeet, O
Skelton, L
Tait, D
Wardle, J
Wynne, C
Yarnold, J
Citation: A. Ashton et al., 8 Gy single fraction radiotherapy for the treatment of metastatic skeletalpain: randomised comparison with a multifraction schedule over 12 months of patient follow-up, RADIOTH ONC, 52(2), 1999, pp. 111-121
Citation: G. Mitchell et al., Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma, RADIOTH ONC, 50(1), 1999, pp. 33-38